Merck & Co.'s Botswana HIV/AIDS Program: the Pricing of Essential Medicines in Developing Markets

Tom Bombelles, Director of International Government Relations at Merck & Co., Inc. speaks on Merck's HIV/AIDS program in Botswana and the pricing of essential medicines in developing markets, more specifically on what sort of business challenges exist in these markets – establishing prices, logistical constraints, pushback/support from governments, the WTO/intellectual property rights, other corporations, NGOs, etc. The lecture was sponsored by International Policy Center and the Gerald R. Ford School of Public Policy and the William Davidson Institute.